Lindsay Short has made several allegations against Neuralink Corp. in her lawsuit filed in California state court. These include:
Neuralink Corp. reportedly fired Lindsay Short the day after she reported her pregnancy to the company's human resources department. The lawsuit alleges that the company claimed the dismissal was due to performance issues.
The primary functions and goals of Neuralink Corp.'s brain-implant device currently in clinical trials are to restore function for paralyzed patients and enable them to control computers and other devices using their thoughts. The device, called Telepathy, is designed to interpret a person's neural activity and allow them to operate a computer or smartphone by simply intending to move – no physical movement or wires are required. The implant contains 1,024 electrodes distributed across 64 threads, which are inserted into a part of the brain related to movement. The device aims to help people with quadriplegia due to spinal cord injury or amyotrophic lateral sclerosis (ALS) gain a new sense of independence by controlling external devices with their thoughts1.